Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Breast 1

Conditions

Breast Neoplasms 8Neutropenia 3Febrile Neutropenia 2Triple Negative Breast Neoplasms 1Lymphoma 1Carcinoma, Non-Small-Cell Lung 1Breastcancer 1Breast Cancer Female 1Bone Neoplasms 1

Interventions

pembrolizumab 2Zoledronic Acid 2Radiation 2tocilizumab 1saracatinib 1poly ICLC 1pegylated granulocyte colony-stimulating factor 1montanide ISA 51 1liposomal doxorubicin 1fludarabine 1flt3 ligand protein 1cc-486 1aldesleukin 1Taxes 1Surveys and Questionnaires 1Standard of Care 1Radiotherapy 1Quality of Life 1Psychology, Positive 1Practice Guidelines as Topic 1Patient Reported Outcome Measures 1Palliative Care 1Paclitaxel 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Methods 1Lomustine 1Irinotecan 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × pegylated granulocyte colony-stimulating factor × Breast × Clear all
NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Peking University

Phase 4 Unknown
217 enrolled
BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡